The Defender is experiencing censorship on many social channels. Be sure to stay in touch with the news that matters by subscribing to our top news of the day. It's free.

Mother-of-Three, 47, Dies After AstraZeneca COVID Jab Caused Blood Clots on Her Brain Which Led to a Stroke

The Daily Mail reported:

A mother-of-three has died after suffering a rare catastrophic reaction to the AstraZeneca coronavirus jab, her family has said.

Lucy Taberer, 47, fell seriously ill after getting the jab and developed blood clots in her brain which caused a stroke.

Her heartbroken fiance, Mark Tomlin, from Aylestone in Leicester, has since spoken about the devastating impact her death has had on the family including the couple’s five-year-old son Orson.

FDA Adds Heart Inflammation Warning to Pfizer, Moderna COVID Vaccines as Experts Call for Full Approval

The Defender reported:

The U.S. Food and Drug Administration (FDA) on June 25 added a warning to patient and provider fact sheets for Pfizer and Moderna COVID vaccines indicating an increased risk of myocarditis and pericarditis following vaccination.

The warning notes reports of adverse events suggest increased risks of myocarditis and pericarditis, particularly following the second dose and with onset of symptoms within a few days after vaccination.

CDC Reports 4,115 Breakthrough COVID Cases Involving Hospitalizations or Deaths

Fox News reported:

The Centers for Disease Control and Prevention (CDC) has received reports of 4,115 patients with COVID-19 vaccine breakthrough cases who were hospitalized or died. Of those cases, 26% of hospitalizations were reported as asymptomatic or not related to COVID-19, and 19% of the 750 fatalities were reported as asymptomatic or not related to COVID-19.

The data, which includes information through June 21, is amid a backdrop of 150 million people who are fully vaccinated in the U.S. Nearly half of the breakthrough cases, or 49%, involve females, and 3,124, or 76%, occurred in patients ages 65 years and older.

San Antonio Teen Participates in Moderna COVID Vaccine Trial for Kids Aged 12-17

KENS 5 reported:

A second vaccine choice for teens could become available if the FDA grants emergency authorization for Moderna to administer its COVID-19 vaccine to children aged 12-17.

A San Antonio girl says she is participating in the trial with hopes it can help kids live a normal life.

“I was a little hesitant at first but I knew the vaccine trial would help get the vaccine out quicker,” Angelina tells KENS 5.

COVID Killed 26 Indonesian Doctors in June — at Least 10 Had Taken China’s Sinovac Vaccine

The Wall Street Journal reported:

At least 10 of the 26 doctors in Indonesia who died from COVID-19 this month had received both doses of the vaccine developed by Sinovac Biotech Ltd., a medical association said, raising questions about the Chinese-made shot that is being used in many parts of the developing world.

The Indonesian Medical Association’s COVID-19 mitigation group is still working to verify the vaccination status of the 16 others, said Dr. Adib Khumaidi, who leads the group. According to the group’s latest figures, over a five-month period, at least 20 doctors who were fully inoculated with Sinovac’s vaccine died from COVID-19, accounting for more than a fifth of total fatalities among doctors during that time span.

51.18% of Mumbai Children Have COVID Antibodies, Says Sero Survey

NDTV reported:

Over 51 per cent of Mumbai’s general paediatric population – those below 18 – have antibodies for COVID-19, a sero survey conducted in the city between April 1 and June 15 has revealed.

2,176 blood samples collected from path labs across Mumbai showed the highest sero prevalence (53.43 per cent) for children between the ages of 10 and 14. Children aged 15-18 showed 51.39 per cent sero prevalence and those between one and four showed 51.04 per cent sero prevalence.

Saudi Arabia to Inoculate Those Aged 12 to 18 With Pfizer Vaccine – Ministry

Reuters via U.S. News and World Report reported:

Saudi Arabia will start inoculating young people aged 12 to 18 against COVID-19 with the Pfizer-BioNtech vaccine after it was approved by the Saudi Food and Drug Authority, the health ministry said in a tweet on Sunday.

Experts Consider if Recipients of J&J COVID Vaccine Need Booster as Delta Variant Takes Hold

The Times of San Diego reported:

Infectious disease experts are weighing the need for booster shots using the Pfizer/BioNTech or Moderna mRNA-based vaccines for Americans who received the Johnson & Johnson one-dose vaccine.

The examination is taking place due to the increasing prevalence of the more contagious Delta coronavirus variant.

Response to COVID Vaccines Varies Widely in Blood Cancer Patients

Medical Xpress reported:

Patients with a type of blood cancer called multiple myeloma had a widely variable response to COVID-19 vaccines—in some cases, no detectable response—pointing to the need for antibody testing and precautions for these patients after vaccination, according to a study that will be published in Cancer Cell this week.

Mount Sinai researchers found that multiple myeloma patients mount variable and sometimes suboptimal responses after receiving the Pfizer-BioNTech or Moderna COVID-19 vaccines. Almost 16 percent of these patients developed no detectable antibodies after both vaccine doses. These findings may be relevant to other cancer patients undergoing treatment and to immunocompromised patients.

London Sees Big Drop in Number of COVID Vaccinations Despite Drive to Get Young People Inoculated

The Evening Standard reported:

The number of jabs being given in the capital has fallen alarmingly in the last week despite efforts to encourage young Londoners to get vaccinated.

A total of 374,941 first and second COVID-19 vaccine doses were administered in the last seven days, almost 52,000 or 12 per cent fewer than the 426,648 given in the previous week, the Standard can reveal.